Intellijoint HIP has received CE Mark (Conformité Européenne) approval in October 2017 and has recently completed registration for entry into the UK. The news was announced today by Intellijoint Surgical Inc., a privately-held Canadian medical technology company, announces entry into the European market beginning with the United Kingdom (UK). Intellijoint Surgical’s flagship product,
Intellijoint HIP is a 3D mini-optical navigation system that provides real-time, intraoperative measurements for cup position, leg length, offset, and hip center of rotation for total hip replacements (THR). This navigation system is suitable for primary or revision THR, regardless of surgical approach, and is compatible with all implant vendors. With an added average operating theatre time of only 2.9 minutes, it is very fast and orthopaedic surgeons become efficient users within five procedures or less. It is accessible and affordably priced, enabling hospitals to ‘pay as you go’ as an alternative to large capital investments.
“In just two short years of commercialization in the United States and Australia, Intellijoint HIP has been used in over 5,000 procedures by some of the world’s top orthopaedic hospitals,” explained Armen Bakirtzian, Intellijoint CEO & Co-Founder. “Entry into the UK will give us access to over an additional 110,000 THRs annually and a launch point for further expansion into Europe.”
Intellijoint HIP provides cup position angles accurate to within less than one degree and leg length measurements accurate to within 0.3 – 0.8 millimetres. Two clinical studies have been accepted for presentation at the ISTA 31st Annual Congress in London October 2018 that further discuss the added accuracy Intellijoint HIP brings for delivering a functional cup position and how Intellijoint HIP can reduce dislocation rates post revision THR.
Allan Gross, MD, an orthopedic surgeon at Mount Sinai Hospital in Toronto, Canada reports, “Intellijoint HIP is innovative navigation that provides measurements and data that I cannot access during non-navigated THR.” He concluded, “I have been able to participate in the evolution of Intellijoint HIP from prototype to a simple fully featured navigation system. International expansion – beginning with the UK – will give surgeons, globally, access to highly accurate navigation for implant positioning without the high cost and operating theatre time-add associated with traditional navigation.”